Biontech Stock – BioNTech SE ADR falls Thursday, underperforms market
The BioNTech SE ADR
slipped 1.62% to $168.00 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
rising 0.82% to 4,201.62 and the Dow Jones Industrial Average
rising 0.93% to 34,548.53. This was the ADR’s third consecutive day of losses. BioNTech SE ADR closed $45.15 below its 52-week high ($213.15), which the company achieved on May 4th.
The ADR underperformed when compared to some of its competitors Thursday, as AbbVie Inc.
rose 0.26% to $116.08 and Amgen Inc.
rose 0.78% to $251.30. Trading volume (9.9 M) eclipsed its 50-day average volume of 2.4 M.